Related Experiment Video
Updated: Mar 20, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation
Background:
Aberrant DNA hypermethylation contributes to many cancers by silencing structurally normal tumor suppressive genes. MicroRNA-153 (miR-153) exerts a tumor suppressive function in glioblastoma multiforme (GBM) by silencing oncogenic targets. However, the mechanism underlying miR-153 regulation in glioma cells has not been studied.
Methods:
The expression levels of miR-153 were determined by real-time PCR and genomic bisulfite modification technique was used to detect the DNA methylation status in the upstream region of miR-153 in GBM, their matched normal adjacent tissues, and the glioblastoma U87 cell line. Following treatment of cells with 5-aza-2'-deoxycitidine (5-aza-dC), the DNA methylation, gene expression and target proteins levels of miR-153 were determined.
Results:
This study confirmed that miR-153 is significantly downregulated and hypermethylated in GBM tissues compared to their matched normal adjacent tissues. Increased methylation level of miR-153 was significantly correlated with reduced miR-153 expression in GBM tissue specimens. Demethylation of cells by 5-aza-dC treatment led to reduction of miR-153 methylation level, re-expression of candidate microRNA, and downregulation of its target proteins levels.
Conclusions:
Our data indicated that miR-153 acts as a tumor suppressor in GBM and is down-regulated by DNA methylation, suggesting that miR-153 may serve as a potential diagnostic or therapeutic target of GBM. (Clin. Lab. 2016;62:573-580. DOI: 10.7754/Clin.Lab.2015.150738)
Insights
DNA hypermethylation silences tumor suppressors in glioblastoma multiforme (GBM). This study shows microRNA-153 (miR-153) is downregulated by methylation in GBM, acting as a tumor suppressor and potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Aberrant DNA hypermethylation is a key mechanism in cancer development, silencing tumor suppressor genes.
- MicroRNA-153 (miR-153) functions as a tumor suppressor in glioblastoma multiforme (GBM) by targeting oncogenes.
- The regulatory mechanisms of miR-153 in glioma cells, particularly its epigenetic control, were previously uninvestigated.
Purpose of the Study:
- To investigate the role of DNA methylation in regulating miR-153 expression in glioblastoma multiforme (GBM).
- To determine if miR-153 functions as a tumor suppressor in GBM and if its expression is epigenetically controlled.
Main Methods:
- Real-time PCR was used to quantify miR-153 expression levels.
- Genomic bisulfite sequencing was employed to assess DNA methylation status in the miR-153 upstream region in GBM tissues and cell lines.
- Cells were treated with 5-aza-2'-deoxycitidine (5-aza-dC) to induce demethylation and assess its effects on miR-153 expression and target proteins.
Main Results:
- miR-153 was found to be significantly downregulated and hypermethylated in GBM tissues compared to adjacent normal tissues.
- A significant inverse correlation was observed between miR-153 methylation levels and its expression in GBM specimens.
- Demethylation treatment with 5-aza-dC restored miR-153 expression and reduced its target protein levels.
Conclusions:
- miR-153 acts as a tumor suppressor in GBM and its downregulation is mediated by DNA hypermethylation.
- These findings suggest that miR-153 holds potential as a diagnostic biomarker or therapeutic target for GBM.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

